Induced smoothing method | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Follow-up time (month) | Intercept | Age of diagnosis | CD4 cell count | |||||||
PE | SE | 95% CI | PE | SE | 95% CI | PE | SE | 95% CI | ||
\(\tau\)=0.05 | ||||||||||
6 | 6.64 | 3.81 | (-0.828, 14.105) | -0.40 | 0.38 | (-1.144, 0.354) | 0.03 | 0.33 | (-0.621, 0.678) | |
12 | -3.90 | 5.21 | (-14.103, 6.307) | -0.40 | 0.51 | (-1.404, 0.608) | 0.13 | 0.69 | (-1.232, 1.485) | |
18 | 6.53 | 4.46 | (-2.215, 15.266) | -0.18 | 0.50 | (-1.157, 0.793) | 0.61 | 0.48 | (-0.324, 1.553) | |
24 | 7.08 | 5.40 | (-3.507, 17.664) | 0.38 | 0.62 | (-0.835, 1.592) | 0.00 | 0.68 | (-1.327, 1.325) | |
\(\tau\)=0.1 | ||||||||||
6 | 4.07 | 4.17 | (-4.108, 12.246) | -0.35 | 0.47 | (-1.282, 0.576) | 0.20 | 0.40 | (-0.589, 0.988) | |
12 | 3.29 | 6.39 | (-9.230, 15.813) | -0.21 | 0.50 | (-1.189, 0.775) | 0.56 | 0.52 | (-0.466, 1.577) | |
18 | 8.31 | 4.85 | (-1.187, 17.813) | -0.36 | 0.57 | (-1.467, 0.749) | -0.01 | 0.54 | (-1.072, 1.057) | |
24 | 12.70 | 4.59 | (3.706, 21.685) | 0.12 | 0.57 | (-0.990, 1.236) | -0.31 | 0.26 | (-0.811, 0.200) | |
\(\tau\)=0.15 | ||||||||||
6 | 0.04 | 3.16 | (-6.165, 6.236) | -0.19 | 0.53 | (-1.224, 0.841) | -0.02 | 0.37 | (-0.748, 0.716) | |
12 | 8.03 | 5.77 | (-3.289, 19.345) | -0.49 | 0.57 | (-1.605, 0.631) | 0.20 | 0.49 | (-0.765, 1.160) | |
18 | 8.95 | 5.14 | (-1.134, 19.025) | -0.11 | 0.57 | (-1.234, 1.012) | 0.11 | 0.52 | (-0.912, 1.129) | |
24 | 9.08 | 5.58 | (-1.846, 20.009) | 0.13 | 0.68 | (-1.203, 1.471) | -0.29 | 0.28 | (-0.841, 0.269) | |
\(\tau\)=0.2 | ||||||||||
6 | 6.34 | 7.24 | (-7.844, 20.529) | -0.22 | 0.55 | (-1.308, 0.864) | -0.01 | 0.32 | (-0.643, 0.630) | |
12 | 11.70 | 7.68 | (-3.346, 26.742) | -0.50 | 0.78 | (-2.037, 1.029) | 0.06 | 0.46 | (-0.846, 0.969) | |
18 | 11.57 | 8.89 | (-5.866, 28.999) | 0.41 | 0.99 | (-1.521, 2.343) | -0.55 | 1.14 | (-2.782, 1.674) | |
24 | 12.87 | 7.83 | (-2.482, 28.215) | 0.03 | 0.80 | (-1.543, 1.603) | -0.32 | 0.31 | (-0.935, 0.299) |